Health Care: Drugs

Sinovac Biotech Ltd (SVA: NASDAQ)

$5.38 n/a | n/a%
09/02/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 63.10M 72.52M 49.22M 56.84M
Cost of Sales 7.96M 14.43M 15.97M 17.36M
Gross Operating Profit 55.14M 58.10M 33.24M 39.48M
Selling, General, and Administrative Expenses 35.12M 34.03M 30.81M 22.21M
Research & Development 11.03M 8.38M 17.04M 9.01M
Operating Income before D & A (EBITDA) 8.99M 15.68M -14.61M 8.27M
Depreciation & Amortization 8.53M 6.84M 4.72M 5.20M
Interest Income 2.68M 2.17M 2.37M 1.40M
Other Income - Net 1.36M 263.00K -851.57K 588.57K
Special Income / Charges 30.00K -88.00K -1.82M 0.00
Total Income Before Interest Expenses (EBIT) 4.53M 11.18M -19.63M 5.05M
Interest Expense 3.41M 3.03M 0.00 384.56K
Pre-Tax Income 1.12M 8.14M -19.63M 4.67M
Income Taxes 1.46M -2.22M -883.90K 5.07M
Minority Interest 515.00K 2.93M -3.90M 445.00K
Net Income From Continuing Operations -336.00K 10.37M -18.75M -399.69K
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -336.00K 10.37M -18.75M -399.69K
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -851.00K 7.44M -14.85M -844.70K
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-366.00K 10.46M -16.93M -399.69K
Preferred Dividends
Net Income Available To Common -336.00K 10.37M -18.75M -399.69K
Basic EPS from Continuing Ops. -0.02 0.13 -0.27 -0.02
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.02 0.13 -0.27 -0.02
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.02 0.13 -0.27 -0.02
Basic Normalized Net Income/Share -0.02 0.14 -0.24 -0.02
EPS fr Continuing Ops. -0.02 0.13 -0.27 -0.02
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.02 0.13 -0.27 -0.02
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.02 0.13 -0.27 -0.02
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.02 0.13 -0.24 -0.02
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SVA

Latest SVA Headlines from TheStreet

More Financial News for SVA

Press Releases for SVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter